Inhalation Anesthesia Market Size By Product (Sevoflurane, Desflurane, Isoflurane), By Application (Induction, Maintenance), Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, China, Australia, India, Brazil, Mexico, South Africa, Saudi Arabia, UAE), Technology Development, Competitive Landscape & Forecast, 2017 - 2024

Choose Licence

 

Inhalation Anesthesia Market is set to exceed USD 1.6 billion by 2024; according to a new research report by Global Market Insights, Inc. Rising number of geriatric population coupled with increasing number of chronic diseases such as cancer, cardiovascular, neurological, and respiratory disorders and introduction of advanced anesthesia will offer lucrative growth opportunities for the inhalation anesthesia market growth. Increasing number of emergency surgeries driving the count of hospital admissions coupled with favorable private and public insurance will drive the inhalation anesthesia market. Growing investment in healthcare infrastructure development in emerging economies and increasing adoption of universal health coverage resulting in demand among public as well as private healthcare setups will propel the business growth. Increasing number of surgeries performed in ambulatory surgical centers will stimulate business growth over the forecast years. Growing adoption of inhalation anesthesia for globally rising prevalence of cataract surgeries, enhanced access to healthcare treatments, and rise in disposable income will fuel the industry growth. Adverse side effects during recovery, procedure or surgery, or wearing off anesthesia coupled with effect like intraoperative discomfort, hypotension, post-lumbar-puncture headache, and potential for neurologic and cardiac toxicity from anesthetics may hamper the inhalation anesthesia market growth. Sevoflurane segment accounted for the highest revenue share in 2016 and will grow at a significant rate over the forecast period owing to growing use in both maintenance and induction. Isoflurane segment will grow at a significant rate pertaining to associated factors like systemic vessels expand and potentiates activities of muscle relaxants, preferred for neurosurgery, and sustained cardiac outputs will boost the business growth. Maintenance accounted for highest revenue share of the application segment in 2016 and will grow at a significant rate over the forecast period owing to factors like safety of airway as nearly all patients that are anesthetized by means of these products are intubated. Increasing use in patients with low oxygen carrying capacities such as the patients with respirational dysfunction or anemia will fuel the segment growth in the coming years. U.S. market was valued over USD 488 million in 2016 and will grow significantly over the coming years. Rising number of plastic surgeries and substantially increasing adoption rate of the process will drive the business growth in U.S. Furthermore, presence of associations that aids in maintaining the standards of anesthesiology will fuel the industry growth in the country. Germany accounted for highest revenue share in the region, owing to increasing chronic conditions associated with elderly population coupled with adoption rate of inhalation anesthesia. Growing prevalence of cancers and cardiovascular disorders accounting for approximately 66% of overall deaths in Germany will drive the industry growth over the forecast years. China will grow at a significant rate owing to its growing research studies in the business and high prevalence of lung cancer occurred due to pollution. Increasing use of sevoflurane and desflurane in general anesthesia pertaining to superiority of awakening afterwards surgical procedure as compared to traditional inhaled anesthetics will drive the industry growth in the country. Presence of organizations and associations offering platform for research and findings for anesthesia and mounting occurrence of chronic conditions will fuel the business growth in India. Brazil is projected to grow at a substantial rate over the forecast period. Increasing prevalence of chronic conditions coupled with high adoption of inhalation anesthesia technique as compared to intravenous anesthesia (AVT) will stimulate business expansion in the country. Some of the companies operating in market are Abbott, Baxter International, Piramal, Lunan Pharmaceutical, Hikma Pharmaceuticals and Halocarbon Products. Introduction of novel product and growing focus on geographical expansion will propel the industry growth. Key industry players will endeavor to reinforce their position in this competitive market by implementing these strategies. Inhalation anesthesia market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2013 to 2024, for the following segments: Inhalation anesthesia market by product Sevoflurane Desflurane Isoflurane Inhalation anesthesia market by application Induction Maintenance The above information is provided for the following regions and countries: North America U.S. Canada Europe Germany UK Italy France Spain Asia Pacific China India Australia Latin America Brazil Mexico Middle East and Africa South Africa Saudi Arabia UAE

 

Report Content Chapter 1. Methodology 1.1. Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.1.4. Market definition 1.1.5. Market definition and forecast assumptions 1.2. Data Sources 1.2.1. Primary 1.2.2. Secondary Chapter 2. Executive Summary 2.1. Inhalation anesthesia industry 360 degree synopsis, 2013 - 2024 2.1.1. Business trends 2.1.2. Product trends 2.1.3. Application trends 2.1.4. Regional trends Chapter 3. Inhalation Anesthesia Industry Insights 3.1. Industry segmentation 3.2. Industry landscape, 2013 - 2024 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Increasing incidence of chronic diseases CVS, respiratory, cancer 3.3.1.2. Growing geriatric population 3.3.1.3. Increased number of surgeries performed in ambulatory surgical centers 3.3.2. Industry pitfalls & challenges 3.3.2.1. Adverse effects of anesthesia 3.4. Growth potential analysis 3.4.1. By Product 3.4.2. By Application 3.5. Regulatory landscape 3.5.1. U.S 3.5.2. Europe 3.6. Reimbursement scenario 3.6.1. U.S 3.6.2. Europe 3.7. Porter's analysis 3.8. Company market share analysis, 2016 3.8.1. Strategy dashboard 3.9. PESTEL analysis Chapter 4. Inhalation Anesthesia Market, By Product 4.1. Global inhalation anesthesia market share by product, 2016 & 2024 4.2. Sevoflurane 4.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million) 4.3. Desflurane 4.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million) 4.4. Isoflurane 4.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million) Chapter 5. Inhalation Anesthesia Market, By Application 5.1. Global inhalation anesthesia market share by application, 2016 & 2024 5.2. Induction 5.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million) 5.3. Maintenance 5.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million) Chapter 6. Inhalation Anesthesia Market, By Region 6.1. Inhalation anesthesia market share by region, 2016 & 2024 6.2. North America 6.2.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million) 6.2.2. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.2.3. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.2.4. U.S. 6.2.4.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.2.4.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.2.5. Canada 6.2.5.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.2.5.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.3. Europe 6.3.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million) 6.3.2. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.3.3. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.3.4. Germany 6.3.4.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.3.4.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.3.5. UK 6.3.5.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.3.5.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.3.6. France 6.3.6.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.3.6.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.3.7. Spain 6.3.7.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.3.7.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.3.8. Italy 6.3.8.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.3.8.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.4. Asia Pacific 6.4.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million) 6.4.2. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.4.3. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.4.4. China 6.4.4.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.4.4.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.4.5. Australia 6.4.5.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.4.5.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.4.6. India 6.4.6.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.4.6.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.5. Latin America 6.5.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million) 6.5.2. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.5.3. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.5.4. Brazil 6.5.4.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.5.4.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.5.5. Mexico 6.5.5.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.5.5.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.6. Middle East & Africa 6.6.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million) 6.6.2. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.6.3. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.6.4. South Africa 6.6.4.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.6.4.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.6.5. Saudi Arabia 6.6.5.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.6.5.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) 6.6.6. UAE 6.6.6.1. Market estimates and forecast, by product, 2013 - 2024 (USD Million) 6.6.6.2. Market estimates and forecast, by application, 2013 - 2024 (USD Million) Chapter 7. Company Profiles 7.1. Baxter International Inc. 7.1.1. Business overview 7.1.2. Financial data 7.1.3. Product landscape 7.1.4. Strategic outlook 7.1.5. SWOT analysis 7.2. Hikma Pharmaceuticals PLC 7.2.1. Business overview 7.2.2. Financial data 7.2.3. Product landscape 7.2.4. Strategic outlook 7.2.5. SWOT analysis 7.3. Mylan Inc. 7.3.1. Business overview 7.3.2. Financial data 7.3.3. Product landscape 7.3.4. Strategic outlook 7.3.5. SWOT analysis 7.4. Eisai Co., Ltd. 7.4.1. Business overview 7.4.2. Financial data 7.4.3. Product landscape 7.4.4. Strategic outlook 7.4.5. SWOT analysis 7.5. Halocarbon Products Corp 7.5.1. Business overview 7.5.2. Financial data 7.5.3. Product landscape 7.5.4. Strategic outlook 7.5.5. SWOT analysis 7.6. Abbott 7.6.1. Business overview 7.6.2. Financial data 7.6.3. Product landscape 7.6.4. Strategic outlook 7.6.5. SWOT analysis 7.7. Piramal 7.7.1. Business overview 7.7.2. Financial data 7.7.3. Product landscape 7.7.4. Strategic outlook 7.7.5. SWOT analysis 7.8. Lunan Pharmaceutical Group 7.8.1. Business overview 7.8.2. Financial data 7.8.3. Product landscape 7.8.4. Strategic outlook 7.8.5. SWOT analysis

Data Tables TABLE 1. Inhalation anesthesia industry 360 degree synopsis, 2013 - 2024 TABLE 2. Global inhalation anesthesia market, 2013 - 2024 (USD Million) TABLE 3. Global inhalation anesthesia market, 2013 - 2024 (250 ml Million Bottles) TABLE 4. Global inhalation anesthesia market, by product, 2013 - 2024 (USD Million) TABLE 5. Global inhalation anesthesia market, by product, 2013 - 2024 (250 ml Million Bottles) TABLE 6. Global inhalation anesthesia market, by application, 2013 - 2024 (USD Million) TABLE 7. Global inhalation anesthesia market, by application, 2013 - 2024 (250 ml Million Bottles) TABLE 8. Global inhalation anesthesia market, by region, 2013 - 2024 (USD Million) TABLE 9. Global inhalation anesthesia market, by region, 2013 - 2024 (250 ml Million Bottles) TABLE 10. Industry impact forces TABLE 11. Sevoflurane market estimates and forecast, by region, 2013 - 2024 (USD Million) TABLE 12. Sevoflurane market estimates and forecast, by region, 2013 - 2024 (250 ml Million Bottles) TABLE 13. Desflurane market estimates and forecast, by region, 2013 - 2024 (USD Million) TABLE 14. Desflurane market estimates and forecast, by region, 2013 - 2024 (250 ml Million Bottles) TABLE 15. Isoflurane market estimates and forecast, by region, 2013 - 2024 (USD Million) TABLE 16. Isoflurane market estimates and forecast, by region, 2013 - 2024 (250 ml Million Bottles) TABLE 17. Sevoflurane induction market estimates and forecast, by region, 2013 - 2024, (USD Million) TABLE 18. Sevoflurane induction market estimates and forecast, by region, 2013 - 2024, (250 ml Million Bottles) TABLE 19. Desflurane induction market estimates and forecast, by region, 2013 - 2024, (USD Million) TABLE 20. Desflurane induction market estimates and forecast, by region, 2013 - 2024, (250 ml Million Bottles) TABLE 21. Isoflurane induction market estimates and forecast, by region, 2013 - 2024, (USD Million) TABLE 22. Isoflurane induction market estimates and forecast, by region, 2013 - 2024, (250 ml Million Bottles) TABLE 23. Sevoflurane maintenance market estimates and forecast, by region 2013 - 2024, (USD Million) TABLE 24. Sevoflurane maintenance market estimates and forecast, by region 2013 - 2024, (250 ml Million Bottles) TABLE 25. Desflurane maintenance market estimates and forecast, by region 2013 - 2024, (USD Million) TABLE 26. Desflurane maintenance market estimates and forecast, by region 2013 - 2024, (250 ml Million Bottles) TABLE 27. Isoflurane maintenance market estimates and forecast, by region 2013 - 2024, (USD Million) TABLE 28. Isoflurane maintenance market estimates and forecast, by region 2013 - 2024, (250 ml Million Bottles) TABLE 29. North America sevoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 30. North America sevoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 31. North America desflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 32. North America desflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 33. North America isoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 34. North America isoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 35. North America inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 36. North America inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 37. North America inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 38. North America inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 39. North America sevoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 40. North America sevoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 41. North America desflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 42. North America desflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 43. North America isoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 44. North America isoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 45. U.S. inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 46. U.S. inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 47. U.S. inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 48. U.S. inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 49. Canada inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 50. Canada inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 51. Canada inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 52. Canada inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 53. Europe sevoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 54. Europe sevoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 55. Europe desflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 56. Europe desflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 57. Europe isoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 58. Europe isoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 59. Europe inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 60. Europe inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 61. Europe inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 62. Europe inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 63. Europe sevoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 64. Europe sevoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 65. Europe desflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 66. Europe desflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 67. Europe isoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 68. Europe isoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 69. Germany inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 70. Germany inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 71. Germany inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 72. Germany inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 73. UK inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 74. UK inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 75. UK inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 76. UK inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 77. France inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 78. France inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 79. France inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 80. France inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 81. Spain inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 82. Spain inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 83. Spain inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 84. Spain inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 85. Italy inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 86. Italy inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 87. Italy inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 88. Italy inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 89. Asia Pacific sevoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 90. Asia Pacific sevoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 91. Asia Pacific desflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 92. Asia Pacific desflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 93. Asia Pacific isoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 94. Asia Pacific isoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 95. Asia Pacific inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 96. Asia Pacific inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 97. Asia Pacific inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 98. Asia Pacific inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 99. Asia Pacific sevoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 100. Asia Pacific sevoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 101. Asia Pacific desflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 102. Asia Pacific desflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 103. Asia Pacific isoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 104. Asia Pacific isoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 105. China inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 106. China inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 107. China inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 108. China inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 109. Australia inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 110. Australia inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 111. Australia inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 112. Australia inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 113. India inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 114. India inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 115. India inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 116. India inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 117. Latin America sevoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 118. Latin America sevoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 119. Latin America desflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 120. Latin America desflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 121. Latin America isoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 122. Latin America isoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 123. Latin America inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 124. Latin America inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 125. Latin America inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 126. Latin America inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 127. Latin America sevoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 128. Latin America sevoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 129. Latin America desflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 130. Latin America desflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 131. Latin America isoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 132. Latin America isoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 133. Brazil inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 134. Brazil inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 135. Brazil inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 136. Brazil inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 137. Mexico inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 138. Mexico inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 139. Mexico inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 140. Mexico inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 141. MEA sevoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 142. MEA sevoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 143. MEA desflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 144. MEA desflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 145. MEA isoflurane market estimates and forecast, by country, 2013 - 2024 (USD Million) TABLE 146. MEA isoflurane market estimates and forecast, by country, 2013 - 2024 (250 ml 000' Bottles) TABLE 147. MEA inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 148. MEA inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 149. MEA inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 150. MEA inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 151. MEA sevoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 152. MEA sevoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 153. MEA desflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 154. MEA desflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 155. MEA isoflurane market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 156. MEA isoflurane market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 157. South Africa inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 158. South Africa inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 159. South Africa inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 160. South Africa inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 161. Saudi Arabia inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 162. Saudi Arabia inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 163. Saudi Arabia inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 164. Saudi Arabia inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) TABLE 165. UAE inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (USD Million) TABLE 166. UAE inhalation anesthesia market estimates and forecast, by product, 2013 - 2024 (250 ml 000' Bottles) TABLE 167. UAE inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (USD Million) TABLE 168. UAE inhalation anesthesia market estimates and forecast, by application, 2013 - 2024 (250 ml 000' Bottles) Charts & Figures FIG. 1 Industry segmentation FIG. 2 Global inhalation anesthesia market, 2013- 2024 (USD Million) FIG. 3 Growth potential analysis, by product FIG. 4 Growth potential analysis, by application FIG. 5 Porter's analysis FIG. 6 PESTEL analysis FIG. 7 Inhalation anesthesia market share by product, 2015 & 2024 FIG. 8 Inhalation anesthesia market share by application, 2015 & 2024 FIG. 9 Inhalation anesthesia market share, by region, 2016 & 2024


Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by Global Market Insights, Inc.

Liquid Crystal Polymer (LCP) Market Size By Application (Electrical & Electronics, Automotive, Consumer Goods, Lighting, Medical), Regional Outlook (U.S., Canada, Mexico, Germany, UK, France, Italy, Russia, China, Japan, India, South Korea, Australia, Malaysia, Thailand, Brazil, Saudi Arabia, UAE, South Africa) Competitive Market Share & Forecast, 2017 - 2024

Liquid Crystal Polymer (LCP) Market is set to exceed USD 650 million by 2024; according to a new research report. Increasing consumer goods demand & strong application outlook in ultra-compact electronic devices like mobiles, laptops & televisions ...

New Pharmaceuticals and Healthcare Reports